984P Relationship between RET fusion partner and treatment outcomes in patients (pts) with non-small cell lung cancer (NSCLC) from the phase I/II ARROW study and real-world data (RWD)

Journal article

Peer reviewed

S.M. Gadgeel, J. Gainor, F. Cappuzzo, E. Garralda, D.H. Lee, J. Mazieres, D-W. Kim, V. Zhu, G. Lopes, S. Miller, …

Annals of oncology, Vol.33(7), pp.S1001-S1002

2022-09

Metrics

2 Record Views

Title: 984P Relationship between RET fusion partner and treatment outcomes in patients (pts) with non-small cell lung cancer (NSCLC) from the phase I/II ARROW study and real-world data (RWD)
Creators: S.M. Gadgeel - Henry Ford Health System
J. Gainor - Massachusetts General Hospital
F. Cappuzzo - Istituti di Ricovero e Cura a Carattere Scientifico
E. Garralda - Vall d'Hebron Institute of Oncology
D.H. Lee - Asan Medical Center
J. Mazieres - Institut universitaire du cancer de Toulouse Oncopole
D-W. Kim - Seoul National University Hospital
V. Zhu - University of California, Irvine
G. Lopes - University of Miami
S. Miller - Blueprint Medicines
M. Nowicka - Roche
H. Trinh
S.M. Arndorfer
A. Rahman - Roche
J. Noe - Roche
Q. Zhang
V. Subbiah - The University of Texas MD Anderson Cancer Center
Publication Details: Annals of oncology, Vol.33(7), pp.S1001-S1002
Publisher: ELSEVIER; AMSTERDAM
Number of pages: 2
Grant note: F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd.
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032860808802976